HYUNDAI BIOSCIENCE CO., LTD. Logo

HYUNDAI BIOSCIENCE CO., LTD.

Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.

048410 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경상북도 김천시 아포읍 아포공단길 106, 김천시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

HYUNDAI BIOSCIENCE CO., LTD. is a clinical-stage biotechnology company focused on developing and commercializing innovative therapeutics through its advanced drug delivery systems (DDS) and bio-fusion technologies. The company's core mission is to create safer and more effective treatments for critical diseases. Its development pipeline features CP-COV03, a broad-spectrum antiviral drug candidate designed to treat viral infections by enhancing cellular autophagy, and Polytaxel, a next-generation anticancer agent engineered to minimize toxicity and patient discomfort. The company's proprietary technology platform, utilizing organic-inorganic hybrid materials, also underpins its commercialized bio-functional products. Through strategic partnerships with global universities and companies, Hyundai Bioscience aims to contribute significantly to human health and life extension.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HYUNDAI BIOSCIENCE CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HYUNDAI BIOSCIENCE CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HYUNDAI BIOSCIENCE CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cross Marketing Group Inc. Logo
Delivers marketing insights via research and digital solutions using a large Japanese consumer panel.
Japan 3675
CrowdWorks Inc. Logo
Japan's largest crowdsourcing service with HR solutions and SaaS to connect companies and talent.
Japan 3900
C&R Research Inc. Logo
Leading South Korean CRO offering end-to-end clinical trial services for life science companies.
South Korea 359090
Curasight A/S Logo
Developing uPAR theranostics to precisely diagnose and treat cancers like brain and prostate.
Denmark CURAS
Cyclezyme AB Logo
Develops enzymatic solutions for recycling plastic waste into new raw materials.
Sweden CYCLE
Exploring for uranium & REEs, critical minerals for the clean energy and tech sectors.
Canada N/A
DBV Technologies Logo
Developing non-invasive skin patch immunotherapy for severe food allergies like peanut and milk.
France DBV
DD GROUP Co.,Ltd. Logo
Operates a diverse portfolio of food service, amusement, and hotel brands.
Japan 3073
A nationwide network of studios offering modern wedding photography and wellness services.
Japan 7372
Dedem SpA Logo
Diversified group providing photo booths, amusement rides, 3D printing, and tech solutions.
Italy DDM

Talk to a Data Expert

Have a question? We'll get back to you promptly.